Insulinoma pathophysiology

	Insulinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Insulinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
X-ray
Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Insulinoma pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Insulinoma pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Insulinoma pathophysiology
CDC on Insulinoma pathophysiology
Insulinoma pathophysiology in the news
Blogs on Insulinoma pathophysiology
Directions to Hospitals Treating Insulinoma
Risk calculators and risk factors for Insulinoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

On microscopic histopathological analysis, solid or gyriform patterns, usually without glands are characteristic findings of insulinoma. Genes involved in the pathogenesis of carcinoid tumor are MEN1 and

Pathophysiology

An insulinoma is a tumor of the pancreas that is derived from beta cells and secretes insulin. It is a rare form of a neuroendocrine tumor. Most insulinomas are benign in that they grow exclusively at their origin within the pancreas, but a minority metastasize. Insulinomas are one of the functional pancreatic neuroendocrine tumor ("functional" because it increases production of insulin). Beta cells secrete insulin in response to increases in blood glucose. The resulting increase in insulin acts to lower blood glucose back to normal levels at which point further secretion of insulin is stopped. In contrast, the secretion of insulin by insulinomas is not properly regulated by glucose and the tumors will continue to secrete insulin causing glucose levels to fall further than normal.

Genetics

Insulinoma can occur in association with inherited syndrome, such as multiple endocrine neoplasia type 1, von Hippel-Lindau syndrome or sporadic.^[1]

Multiple endocrine neoplasia type 1 is an autosomal dominant disorder caused by alterations of the MEN1 gene located at chromosomal region 11q13.
Approximately 10% of insulinomas are multiple and 10% malignant.^[2]

Microscopic Pathology

On microscopic histopathological analysis characteristic findings of insulinoma are:

Solid or gyriform patterns, usually without glands

Histopathology of pancreatic endocrine tumor (insulinoma). H&E stain^[3]
Histopathology of pancreatic endocrine tumor (insulinoma)^[3]
Histopathology of pancreatic endocrine tumor (insulinoma). Chromogranin A immunostain^[3]
Histopathology of pancreatic endocrine tumor (insulinoma). Insulin immunostain^[3]